SEC 13D/G
ELVN - Enliven Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified
Keywords
ELVNELVN SEC filingELVN institutional investorEnliven TherapeuticsInc.Enliven TherapeuticsInc. SEC filingEnliven TherapeuticsInc. stockSEC 13DSEC 13GThinkSabiostocks simplifiedHealthcareSEC 13D/Gstock market 2026institutional holdings
Share this post
💬 Comments
Loading comments…
Leave a comment
